News
02/03/2022 - 16:39
Article
More than €140 million raised in 2021by Institut CURIE START-UPS (Carnot Institute)
02/03/2022 - 16:33
Article
Bringing artificial intelligence in machine vision to optimise bridge maintenance
02/03/2022 - 16:20
Article
Inria and Dassault Systèmes Form Strategic Alliance for a European Digital Trusted Platform
02/03/2022 - 16:03
Article
AVATAR MEDICAL raises €1.2 million for its virtual reality medical imaging solution for Surgeons
03/25/2021 - 10:31
Article
Partnership agreement between the Calym Carnot Institute and IQVIA
01/23/2020 - 17:05
Article
LETI INNOVATION DAYS - reported October 12-16 in Grenoble.
01/14/2020 - 14:35
Vidéo
CES 2020 : Interview Valery Cervantes Esprit Project Coordinator - Carnot Energies du futur
01/14/2020 - 14:34
Vidéo
CES 2020: Interview Sophie Morales LSIV Lab manager - Carnot Leti
01/14/2020 - 14:33
Vidéo
CES 2020: Interview Lionel Rudant Founder & CTO - Anteneo - Carnot Leti
01/14/2020 - 14:32
Vidéo
CES 2020: Interview Dimitri Ktenas Head of Wireless Technologie - Carnot Leti
11/06/2019 - 12:01
Article
Chimie Balard Cirimat Carnot Institute at European Utility Week in Paris
04/18/2019 - 13:42
Article
Novel antibiotics: DEINOVE signs an agreement with the Institut Pasteur (Pasteur MS Carnot Institute) to explore the potential of new targeted strains
DEINOVE, a French biotech company that uses a disruptive approach to develop innovative antibiotics and bio-based active ingredients for cosmetics and nutrition, has announced that it will benefit from the Institut Pasteur's provision of biological resources for the research of new antimicrobial agents from original strains. The Institut Pasteur (Pasteur MS Carnot Institute), one of the most renowned worldwide players in the area of infectious disease research, will entrust a targeted selection of strains from their bacterial collection to DEINOVE.
04/02/2019 - 17:30
Article
